BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 31144617)

  • 21. Constitutive neuregulin-1/ErbB signaling contributes to human vestibular schwannoma proliferation.
    Hansen MR; Roehm PC; Chatterjee P; Green SH
    Glia; 2006 Apr; 53(6):593-600. PubMed ID: 16432850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigenomic Profiling Discovers Trans-lineage SOX2 Partnerships Driving Tumor Heterogeneity in Lung Squamous Cell Carcinoma.
    Sato T; Yoo S; Kong R; Sinha A; Chandramani-Shivalingappa P; Patel A; Fridrikh M; Nagano O; Masuko T; Beasley MB; Powell CA; Zhu J; Watanabe H
    Cancer Res; 2019 Dec; 79(24):6084-6100. PubMed ID: 31551362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Trop2 causes ErbB3 activation through a neuregulin-1-dependent mechanism in the mesenchymal subtype of HNSCC.
    Zhang K; Jones L; Lim S; Maher CA; Adkins D; Lewis J; Kimple RJ; Fertig EJ; Chung CH; Van Tine BA; Ellis MJ; Herrlich A; Michel LS
    Oncotarget; 2014 Oct; 5(19):9281-94. PubMed ID: 25238142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. NRG1 / ERBB3 signaling in melanocyte development and melanoma: inhibition of differentiation and promotion of proliferation.
    Buac K; Xu M; Cronin J; Weeraratna AT; Hewitt SM; Pavan WJ
    Pigment Cell Melanoma Res; 2009 Dec; 22(6):773-84. PubMed ID: 19659570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ING5 inhibits cell proliferation and invasion in esophageal squamous cell carcinoma through regulation of the Akt/NF-κB/MMP-9 signaling pathway.
    Zhang GJ; Zhao J; Jiang ML; Zhang LC
    Biochem Biophys Res Commun; 2018 Feb; 496(2):387-393. PubMed ID: 29326045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DeltaN TP63 reactivation, epithelial phenotype maintenance, and survival in lung squamous cell carcinoma.
    Pallier K; Cazes A; El Khattabi L; Lecchi C; Desroches M; Danel C; Riquet M; Fabre-Guillevin E; Laurent-Puig P; Blons H
    Tumour Biol; 2012 Feb; 33(1):41-51. PubMed ID: 21986963
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung.
    Shin DH; Lee D; Hong DW; Hong SH; Hwang JA; Lee BI; You HJ; Lee GK; Kim IH; Lee YS; Han JY
    Oncotarget; 2016 Oct; 7(43):69450-69465. PubMed ID: 27626312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuregulin/erythroblastic leukemia viral oncogene homolog 3 autocrine loop contributes to invasion and early recurrence of human hepatoma.
    Hsieh SY; He JR; Hsu CY; Chen WJ; Bera R; Lin KY; Shih TC; Yu MC; Lin YJ; Chang CJ; Weng WH; Huang SF
    Hepatology; 2011 Feb; 53(2):504-16. PubMed ID: 21246584
    [TBL] [Abstract][Full Text] [Related]  

  • 29. TP63 links chromatin remodeling and enhancer reprogramming to epidermal differentiation and squamous cell carcinoma development.
    Yi M; Tan Y; Wang L; Cai J; Li X; Zeng Z; Xiong W; Li G; Li X; Tan P; Xiang B
    Cell Mol Life Sci; 2020 Nov; 77(21):4325-4346. PubMed ID: 32447427
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multifactorial ERβ and NOTCH1 control of squamous differentiation and cancer.
    Brooks YS; Ostano P; Jo SH; Dai J; Getsios S; Dziunycz P; Hofbauer GF; Cerveny K; Chiorino G; Lefort K; Dotto GP
    J Clin Invest; 2014 May; 124(5):2260-76. PubMed ID: 24743148
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identifying pathways regulating the oncogenic p53 family member ΔNp63 provides therapeutic avenues for squamous cell carcinoma.
    Pokorna Z; Vyslouzil J; Vojtesek B; Coates PJ
    Cell Mol Biol Lett; 2022 Feb; 27(1):18. PubMed ID: 35196980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis.
    Moses MA; George AL; Sakakibara N; Mahmood K; Ponnamperuma RM; King KE; Weinberg WC
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31340447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Blocking NRG1 and other ligand-mediated Her4 signaling enhances the magnitude and duration of the chemotherapeutic response of non-small cell lung cancer.
    Hegde GV; de la Cruz CC; Chiu C; Alag N; Schaefer G; Crocker L; Ross S; Goldenberg D; Merchant M; Tien J; Shao L; Roth L; Tsai SP; Stawicki S; Jin Z; Wyatt SK; Carano RA; Zheng Y; Sweet-Cordero EA; Wu Y; Jackson EL
    Sci Transl Med; 2013 Feb; 5(171):171ra18. PubMed ID: 23390248
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ZNF750 is a lineage-specific tumour suppressor in squamous cell carcinoma.
    Hazawa M; Lin DC; Handral H; Xu L; Chen Y; Jiang YY; Mayakonda A; Ding LW; Meng X; Sharma A; Samuel S; Movahednia MM; Wong RW; Yang H; Tong C; Koeffler HP
    Oncogene; 2017 Apr; 36(16):2243-2254. PubMed ID: 27819679
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of bivalent factor DLX5 cooperates with master regulator TP63 to promote squamous cell carcinoma.
    Huang Y; Yang Q; Zheng Y; Lin L; Xu X; Xu XE; Silva TC; Hazawa M; Peng L; Cao H; Ding Y; Lu D; Berman BP; Xu LY; Li EM; Yin D
    Nucleic Acids Res; 2021 Sep; 49(16):9246-9263. PubMed ID: 34370013
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FoxA1 and FoxA2 drive gastric differentiation and suppress squamous identity in NKX2-1-negative lung cancer.
    Camolotto SA; Pattabiraman S; Mosbruger TL; Jones A; Belova VK; Orstad G; Streiff M; Salmond L; Stubben C; Kaestner KH; Snyder EL
    Elife; 2018 Nov; 7():. PubMed ID: 30475207
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C Virus Activates a Neuregulin-Driven Circuit to Modify Surface Expression of Growth Factor Receptors of the ErbB Family.
    Stindt S; Cebula P; Albrecht U; Keitel V; Schulte am Esch J; Knoefel WT; Bartenschlager R; Häussinger D; Bode JG
    PLoS One; 2016; 11(2):e0148711. PubMed ID: 26886748
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Copy number changes of target genes in chromosome 3q25.3-qter of esophageal squamous cell carcinoma: TP63 is amplified in early carcinogenesis but down-regulated as disease progressed.
    Yen CC; Chen YJ; Pan CC; Lu KH; Chen PC; Hsia JY; Chen JT; Wu YC; Hsu WH; Wang LS; Huang MH; Huang BS; Hu CP; Chen PM; Lin CH
    World J Gastroenterol; 2005 Mar; 11(9):1267-72. PubMed ID: 15761962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression.
    Ruptier C; De Gaspéris A; Ansieau S; Granjon A; Tanière P; Lafosse I; Shi H; Petitjean A; Taranchon-Clermont E; Tribollet V; Voeltzel T; Scoazec JY; Maguer-Satta V; Puisieux A; Hainaut P; Cavard C; Caron de Fromentel C
    Oncogene; 2011 Nov; 30(46):4656-65. PubMed ID: 21643019
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.